Episode 22: In the Clinic - Discussing molecular profiling in endometrial cancer with Dr Angela George

Send us Fan MailIn recent years we have seen a marked change in the landscape of treatment for endometrial cancer.This has been driven by understanding the different molecular subtypes of endometrial cancer.POLE - with an excellent prognosisMMR deficient - with good prognosis and option for immunotherapyNo Specific molecular profile - intermediate outcome and work still to be doneP53 mutant - with a poorer outcomeDr Angela George from the Royal Marsden Hospital has a specialist interest in genomics and shares her expertise and knowledge on this fascinating area of gynaecological cancers.